Lookup NU author(s):
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2017, Springer Science+Business Media B.V., part of Springer Nature. Hereditary hemorrhagic telangiectasia is an autosomal dominant trait affecting approximately 1 in 5000 people. A pathogenic DNA sequence variant in the ENG, ACVRL1 or SMAD4 genes, can be found in the majority of patients. The 12th International Scientific HHT Conference was held on June 8–11, 2017 in Dubrovnik, Croatia to present and discuss the latest scientific achievements, and was attended by over 200 scientific and clinical researchers. In total 174 abstracts were accepted of which 58 were selected for oral presentations. This article covers the basic science and clinical talks, and discussions from three theme-based workshops. We focus on significant emergent themes and unanswered questions. Understanding these topics and answering these questions will help to define the future of HHT research and therapeutics, and ultimately bring us closer to a cure.
Author(s): Andrejecsk JW, Hosman AE, Botella LM, Shovlin CL, Arthur HM, Dupuis-Girod S, Buscarini E, Hughes CCW, Lebrin F, Mummery CL, Post MC, Mager JJ
Publication type: Article
Publication status: Published
Print publication date: 01/02/2018
Online publication date: 16/11/2017
Acceptance date: 02/04/2016
ISSN (print): 0969-6970
ISSN (electronic): 1573-7209
Publisher: Springer Netherlands
Altmetrics provided by Altmetric